Please assess the completion status of the following clinical trial:

Trial Title: Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy women of 18 years of age or older and of non-childbearing potential~* Clinical symptoms of overactive bladder for 6 months or longer including at least one of the following:~  1. frequent urination (that is, having to go to the bathroom 8 or more times per day);~ 2. symptoms of urinary urgency, which is experiencing a sudden need to pass urine that is difficult to hold back; or the complaint of waking at night two ore more times to urinate;~ 3. urge urinary incontinence, which is the complaint of leakage of urine that cannot be stopped, accompanied by or immediately preceded by urgency 5 or more times per week.~* Non-response or poor tolerance to previous treatment for symptoms of overactive bladder and do not wish to continue with that treatment.~Exclusion Criteria:~* A woman with a positive serum (HCG) pregnancy test or who is lactating~* History of three or more culture-documented recurrent urinary tract infections per year~* Current history or previous diagnosis of painful bladder syndrome (interstitial cystitis) with pain in the region of the pelvis, perineum, or lower abdomen relieved by voiding~* Current history of neurological bladder dysfunction~* A life expectancy of less than 12 months~* Current history of Grade 2 or greater cystocele~* An indwelling urethral catheter or need for clean intermittent self- catheterization~* Recent heart attack~* Uncontrolled diabetes~* Latex allergy~* Stress urinary incontinence as determined by observation of the participant coughing while standing with a full bladder and/or response of 2 or 3 on the following Stress Urinary Incontinence question: Do you experience leakage when laughing, coughing, lifting heavy objects or other types of discreet, moderately intense activities? 0=NONE: No leakage. 1=MILD: Minimal leakage on rare occasions during these types of activities; easily tolerated; do not use pads for this. 2=MODERATE: Enough leakage that it requires occasional use of pads and may interfere with usual activity and tasks. 3=SEVERE: Extreme leakage and discomfort that stops all activity and tasks and requires the use of pads on all occasions

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- hMaxi-K 5000 µg/mL (Type: EXPERIMENTAL): 5000 micrograms (µg)/90 milliliter (mL) intravesical instillation
- hMaxi-K 10000 µg/mL (Type: EXPERIMENTAL): 10000 µg/90 mL intravesical instillation
- Placebo (Type: PLACEBO_COMPARATOR): Matching placebo (PBS-20% sucrose)

Based on this trial design, predict the completion outcome and termination type (if applicable).